LYUDMILA EMAG: Open Payments
NPI 1619126588 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 28 payments from 8 companies in 2025. Trend: 2023 $470 · 2024 $675 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 18 | $460 |
| Arcutis Biotherapeutics, Inc. | 1 | $161 |
| Antares Pharma, Inc. | 3 | $59 |
| Teleflex LLC | 2 | $49 |
| UROGEN PHARMA, INC. | 1 | $33 |
| Astellas Pharma US Inc | 1 | $23 |
| TOLMAR, INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: GEMTESA, XYOSTED, JELMYTO, BARRIGEL, UROLIFT, Xtandi, ELIGARD, Nubeqa.
Industry payments across NY — which companies pay providers there.
